Viewing Study NCT01202032

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-02-04 @ 4:06 AM
Study NCT ID: NCT01202032
Status: COMPLETED
Last Update Posted: 2016-05-18
First Post: 2010-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors
Sponsor: Centre Leon Berard
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Renal Cell Carcinoma View
None Advanced Refractory Solid Tumors Histologically or Cytologically Confirmed View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic renal cell carcinoma View
None Advanced solid tumors View
None Dose escalation View
None Association Pazopanib-Bevacizumab View